Physician profile
Haylee Goad
NPI 1417626409
$3,814.67
in general payments reported to CMS, 2019-2025
25 companies · $675 in 2025
The $675 reported for 2025 was more than what 80% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,244 · 2023: $653 · 2024: $1,243 · 2025: $675.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,201 · Travel and Lodging: $370.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,201.19 |
| Travel and Lodging | $369.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Relievant Medsystems, INC. | $966.19 | 2022-2023 | Intracept |
| Curonix LLC | $606.08 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Collegium Pharmaceutical, INC. | $294.69 | 2022-2025 | Belbuca, Xtampza |
| Boston Scientific Corporation | $269.93 | 2022-2025 | Wavewriter Alpha Prime 16, General - Pain Management, Infinion 16 |
| Averitas Pharma INC. | $260.07 | 2023-2024 | Qutenza |
| Janssen Pharmaceuticals, INC | $226.48 | 2024-2025 | Spravato |
| Grt US Holding, INC. | $211.17 | 2022 | |
| Si-Bone, INC. | $182.07 | 2024 | |
| Medtronic, INC. | $116.15 | 2023-2024 | Intellis Adaptivestim, Kyphon Express II Kyphopak Tray, Synchromedii |
| Globus Medical, INC. | $110.94 | 2025 | Senza |
| Vertex Pharmaceuticals Incorporated | $103.50 | 2025 | |
| Valinor Pharma, LLC | $68.93 | 2025 | Movantik |
| Spinal Simplicity, LLC | $66.76 | 2025 | Ha Minuteman G3-R |
| Amgen INC. | $59.00 | 2022-2023 | Evenity |
| Abbvie INC. | $42.75 | 2022-2023 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orexo US, INC. | $33.48 | 2025 | Zubsolv |
| Lundbeck LLC | $32.40 | 2024 | Vyepti |
| Bioventus LLC | $30.69 | 2025 | Xcell |
| Scilex Pharmaceuticals INC. | $21.43 | 2025 | |
| Tonix Medicines, INC. | $21.30 | 2025 | Tonmya |
| Spr Therapeutics, INC | $20.73 | 2025 | Sprint Pns System |
| Angiodynamics, INC. | $19.94 | 2023 | Venacure 1470 Pro |
| Saluda Medical Americas, INC. | $17.07 | 2024 | Evoke |
| Medline Industries LP | $17.00 | 2023 | |
| Mml US, INC. | $15.92 | 2023 | Reactiv8 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Haylee Goad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.